{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:09:24Z","timestamp":1775707764148,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Cryoprobe Prodigy"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.biomaterials.2014.04.072","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T20:30:48Z","timestamp":1400272248000},"page":"7088-7100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Lavasanifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Chris","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2014.04.072_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc887","article-title":"How acute promyelocytic leukaemia revived arsenic","volume":"2","author":"Zhu","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2146\/ajhp080342","article-title":"Arsenic trioxide as first-line treatment for acute promyelocytic leukemia","volume":"66","author":"Leu","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib3","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE). 2. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib4","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1182\/blood.V94.10.3315.422k16_3315_3324","article-title":"Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients","volume":"94","author":"Niu","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib5","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2004.09.008","article-title":"Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy","volume":"22","author":"de Botton","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood-2009-07-230805","article-title":"Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia","volume":"115","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib8","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.94.8.3978","article-title":"Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia","volume":"94","author":"Zhu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML-RAR alpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RAR alpha oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib11","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-02-329367","article-title":"Revisiting the differentiation paradigm in acute promyelocytic leukemia","volume":"117","author":"Ablain","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm.1891","article-title":"Eradication of acute promyelocytic leukemia-initiating cells through PML-RAR\u03b1 degradation","volume":"14","author":"Nasr","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib13","first-page":"3345","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL)1. As2O3 exerts dose-dependent dual effects on APL cells","volume":"89","author":"Chen","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3748\/wjg.v9.i5.930","article-title":"Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity","volume":"9","author":"Wang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1081\/CNV-200029068","article-title":"Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells","volume":"22","author":"Li","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/1933719108324134","article-title":"Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells","volume":"15","author":"Bae-Jump","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.23284","article-title":"Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma","volume":"112","author":"Tarhini","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ctrv.2007.05.001","article-title":"Arsenical-based cancer drugs","volume":"33","author":"Dilda","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cdd.4401389","article-title":"Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine","volume":"11","author":"Maeda","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib20","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.3748\/wjg.v11.i36.5633","article-title":"Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in\u00a0vitro","volume":"11","author":"Lin","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib21","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-04-2800","article-title":"19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia","volume":"65","author":"Kumagai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib22","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/sj.leu.2404891","article-title":"Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity","volume":"21","author":"Diaz","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib23","first-page":"H18","article-title":"Nanomaterials: applications in cancer imaging and therapy","volume":"23","author":"Barreto","year":"2011","journal-title":"Adv Mater"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/17425247.2012.679927","article-title":"Nanoparticles as delivery carriers for anticancer prodrugs","volume":"9","author":"Fang","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1081\/LPR-120039661","article-title":"Arsenic trioxide liposomes: encapsulation efficiency and in\u00a0vitro stability","volume":"14","author":"Kallinteri","year":"2004","journal-title":"J\u00a0Liposome Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2007.06.048","article-title":"In\u00a0vivo distribution of arsonoliposomes: effect of vesicle lipid composition","volume":"347","author":"Zagana","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib27","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1021\/ja064864h","article-title":"Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release","volume":"128","author":"Chen","year":"2006","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib28","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/1535-7163.MCT-09-0045","article-title":"Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide","volume":"8","author":"Chen","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/08982104.2010.483597","article-title":"Development and modeling of arsenic trioxide-loaded thermosensitive liposomes for anticancer drug delivery","volume":"21","author":"Winter","year":"2011","journal-title":"J\u00a0Liposome Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib30","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/1078-0432.CCR-10-0068","article-title":"A\u00a0novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer","volume":"16","author":"Ahn","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/03639040801926733","article-title":"Evaluation of arsenic trioxide-loaded albumin nanoparticles as carriers: preparation and antitumor efficacy","volume":"34","author":"Yang","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1004-9541(08)60005-1","article-title":"Preparation and in\u00a0vitro studies of stealth PEGylated PLGA nanoparticles as carriers for arsenic trioxide","volume":"15","author":"Wang","year":"2007","journal-title":"Chin J Chem Eng"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(97)00164-8","article-title":"Methoxy poly(ethylene glycol) epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization","volume":"51","author":"Shin","year":"1998","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2006.11.010","article-title":"In\u00a0vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration","volume":"65","author":"Liu","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib35","series-title":"Purification of laboratory chemicals","author":"Armarego","year":"2009"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib36","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s11095-008-9673-5","article-title":"Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells","volume":"25","author":"Xiong","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib37","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1021\/ma0613786","article-title":"Novel self-associating poly(ethylene oxide)-block-poly(epsilon-caprolactone) block copolymers with functional side groups on the polyester block for drug delivery","volume":"39","author":"Mahmud","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0003-2697(84)90786-3","article-title":"Sensitive quantitative-analysis of disulfide bonds in polypeptides and proteins","volume":"138","author":"Thannhauser","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0076-6879(87)43020-6","article-title":"Analysis for disulfide bons in peptides and proteins","volume":"143","author":"Thannhauser","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib41","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1248\/cpb.31.1296","article-title":"Fluorometric analysis of the micelle formation process of surfactants in aqueous-solution. 1. Utility of pyrene in determination of the critical micelle concentration","volume":"31","author":"Ohyashiki","year":"1983","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/ma00005a010","article-title":"Polymer micelle formation. 3. poly(styrene-ethylene oxide) block copolymer micelle formation in water \u2013 a fluorescence probe study","volume":"24","author":"Wilhelm","year":"1991","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2010.01.015","article-title":"Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery","volume":"389","author":"Shahin","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0166-6622(86)80340-7","article-title":"Polymer surfactant interaction. 1. Uncharged water-soluble polymers and charged surfactants","volume":"19","author":"Goddard","year":"1986","journal-title":"Colloid Surf"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib45","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1021\/cr300015c","article-title":"Arsenic binding to proteins","volume":"113","author":"Shen","year":"2013","journal-title":"Chem Rev"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02986314","article-title":"Determination of chemical warfare agents in soil and material samples \u2013 gas chromatographic analysis of phenylarsenic compounds (sternutators) (1st communication)","volume":"4","author":"Haas","year":"1997","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1039\/B816980B","article-title":"Cytotoxicity of arsenic-containing chemical warfare agent degradation products with metallomic approaches for metabolite analysis","volume":"1","author":"Kroening","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/cpb.55.389","article-title":"Conventional synthesis of amphiphilic block copolymer utilized for polymeric micelle by mechanochemical solid-state polymerization","volume":"55","author":"Kondo","year":"2007","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib49","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1021\/la060229d","article-title":"Effects of SDS on the thermo- and pH-sensitive structural changes of the poly(acrylic acid)-based copolymer containing both poly(N-isopropylacrylamide) and monomethoxy poly(ethylene glycol) grafts in water","volume":"22","author":"Hsu","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib50","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1021\/la048848e","article-title":"Mixed self-assembly of poly(ethylene oxide)-b-poly(epsilon-caprolactone) copolymers and sodium dodecyl sulfate in aqueous solution","volume":"20","author":"Vangeyte","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib51","first-page":"489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib52","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0891-5849(99)00176-8","article-title":"Biologic and pharmacologic regulation of mammalian glutathione synthesis","volume":"27","author":"Griffith","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/clinchem\/42.1.64","article-title":"Blood glutathione concentrations in a large-scale human study","volume":"42","author":"Richie","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.biomaterials.2014.04.072_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/63.1.57","article-title":"Mechanisms for the cytotoxicity of cysteamine","volume":"63","author":"Jeitner","year":"2001","journal-title":"Toxicol Sci"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214004700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214004700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:03:13Z","timestamp":1758902593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961214004700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":54,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0142961214004700"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.072","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}